Enikő Kulcsár - Concepedia

Concepedia

Author

Enikő Kulcsár

Semmelweis University

Also Known As

E. Kulcsár, Eniko Kulcsar, Enikő Kulcsár

13

Publications

3.6K

Citations

6

H-Index

16

Concepts

All Affiliations

Semmelweis University Universidad De Santander Oregon Health & Science University Universidad de La Frontera Instituto Dante Pazzanese de Cardiologia

EK

About

Enikő Kulcsár is an author at Semmelweis University specializing in metabolic syndrome, diabetes, and medicine.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	3	3	3.5K
2	Diabetes	3	3	3.5K
3	Health Sciences	1	1	33
4	Public Health	1	1	2.8K
5	Health Policy	1	1	2.8K

Enikő Kulcsár

×

4

Publications

3.6K

Citations

4

H-Index

	Year	Citations
Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial Hertzel C. Gerstein, Helen M. Colhoun, Gilles R. Dagenais, The Lancet Metabolic SyndromeDiabetes ManagementCardiovascular DiseaseHealth PolicyCardiovascular Outcomes	2019	2.8K
Dulaglutide and renal outcomes in type 2 diabetes: an exploratory analysis of the REWIND randomised, placebo-controlled trial Hertzel C. Gerstein, Helen M. Colhoun, Gilles R. Dagenais, The Lancet Metabolic SyndromeDiabetes ManagementUrologyChronic Kidney DiseaseDiabetes	2019	600
Improvement of Insulin Sensitivity by a Novel Drug, BGP-15, in Insulin-resistant Patients: A Proof of Concept Randomized Double-blind Clinical Trial Botond Literáti-Nagy, Enikő Kulcsár, Zs. Literáti-Nagy, Hormone and Metabolic Research	2009	112
Beneficial effect of the insulin sensitizer (HSP inducer) BGP-15 on olanzapine-induced metabolic disorders Botond Literáti-Nagy, Eva Péterfai, Enikő Kulcsár, Brain Research Bulletin ObesityMetabolic SyndromeDiabetes ManagementMedicineHsp Inducer	2010	33

Page 1